These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30919885)

  • 1. Modeling Regional Transmission and Containment of a Healthcare-associated Multidrug-resistant Organism.
    Paul P; Slayton RB; Kallen AJ; Walters MS; Jernigan JA
    Clin Infect Dis; 2020 Jan; 70(3):388-394. PubMed ID: 30919885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Interventions to Reduce the Spread of Multidrug-Resistant Organisms Between Health Care Facilities in a Region.
    Bartsch SM; Wong KF; Mueller LE; Gussin GM; McKinnell JA; Tjoa T; Wedlock PT; He J; Chang J; Gohil SK; Miller LG; Huang SS; Lee BY
    JAMA Netw Open; 2021 Aug; 4(8):e2119212. PubMed ID: 34347060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection control measures and prevalence of multidrug-resistant organisms in non-hospital care settings in northeastern Germany: results from a one-day point prevalence study.
    Hübner NO; Dittmann K; Begunk R; Kramer A;
    J Hosp Infect; 2017 Nov; 97(3):234-240. PubMed ID: 28797758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California.
    McKinnell JA; Singh RD; Miller LG; Kleinman K; Gussin G; He J; Saavedra R; Dutciuc TD; Estevez M; Chang J; Heim L; Yamaguchi S; Custodio H; Gohil SK; Park S; Tam S; Robinson PA; Tjoa T; Nguyen J; Evans KD; Bittencourt CE; Lee BY; Mueller LE; Bartsch SM; Jernigan JA; Slayton RB; Stone ND; Zahn M; Mor V; McConeghy K; Baier RR; Janssen L; O'Donnell K; Weinstein RA; Hayden MK; Coady MH; Bhattarai M; Peterson EM; Huang SS
    Clin Infect Dis; 2019 Oct; 69(9):1566-1573. PubMed ID: 30753383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European survey of management of patients with multidrug-resistant organisms in rehabilitation facilities.
    Doherty A; McNicholas S; Burger H; Boldrini P; Delargy M
    Eur J Phys Rehabil Med; 2019 Aug; 55(4):418-423. PubMed ID: 30781935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
    Lee BY; Bartsch SM; Wong KF; McKinnell JA; Slayton RB; Miller LG; Cao C; Kim DS; Kallen AJ; Jernigan JA; Huang SS
    Am J Epidemiol; 2016 Mar; 183(5):471-9. PubMed ID: 26861238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional impact of multidrug-resistant organism prevention bundles implemented by facility type: A modeling study.
    Cincotta SE; Walters MS; Ham DC; Octaria R; Healy JM; Slayton RB; Paul P
    Infect Control Hosp Epidemiol; 2024 Feb; ():1-8. PubMed ID: 38415308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policies for Controlling Multidrug-Resistant Organisms in US Healthcare Facilities Reporting to the National Healthcare Safety Network, 2014.
    Weiner LM; Webb AK; Walters MS; Dudeck MA; Kallen AJ
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1105-8. PubMed ID: 27350394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing multidrug-resistant organisms in home care and hospice: surveillance, prevention, and control.
    McGoldrick M; Rhinehart E
    Home Healthc Nurse; 2007 Oct; 25(9):580-6; quiz 587-8. PubMed ID: 18049254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Web-Based Interactive Tool to Identify Facilities at Risk of Receiving Patients with Multidrug-Resistant Organisms.
    Octaria R; Chan A; Wolford H; Devasia R; Moon TD; Zhu Y; Slayton RB; Kainer MA
    Emerg Infect Dis; 2020 Sep; 26(9):2046-2053. PubMed ID: 32818409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.
    Slayton RB; Toth D; Lee BY; Tanner W; Bartsch SM; Khader K; Wong K; Brown K; McKinnell JA; Ray W; Miller LG; Rubin M; Kim DS; Adler F; Cao C; Avery L; Stone NT; Kallen A; Samore M; Huang SS; Fridkin S; Jernigan JA
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(30):826-31. PubMed ID: 26247436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Genome Sequencing To Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission within and between Regional Long-Term Acute-Care Hospitals.
    Han JH; Lapp Z; Bushman F; Lautenbach E; Goldstein EJC; Mattei L; Hofstaedter CE; Kim D; Nachamkin I; Garrigan C; Jain T; Bilker W; Wolford HM; Slayton RB; Wise J; Tolomeo P; Snitkin ES
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan.
    Lee CM; Lai CC; Chiang HT; Lu MC; Wang LF; Tsai TL; Kang MY; Jan YN; Lo YT; Ko WC; Tseng SH; Hsueh PR
    J Microbiol Immunol Infect; 2017 Apr; 50(2):133-144. PubMed ID: 28373038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gram-negative multidrug-resistant organism colonization in a US military healthcare facility in Iraq.
    Ake J; Scott P; Wortmann G; Huang XZ; Barber M; Wang Z; Nikolich M; Van Echo D; Weintrob A; Lesho E
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):545-52. PubMed ID: 21558766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
    Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective.
    Backman C; Taylor G; Sales A; Marck PB
    Am J Infect Control; 2011 Jun; 39(5):368-378. PubMed ID: 21429622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and risk factors of multi-drug resistant organism colonization among long-term care facilities in Gran Canaria (Spain)].
    Del Rosario-Quintana C; Tosco-Núñez T; Lorenzo L; Martín-Sánchez AM; Molina-Cabrillana J
    Rev Esp Geriatr Gerontol; 2015; 50(5):232-6. PubMed ID: 25576447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey.
    Vaillant L; Birgand G; Esposito-Farese M; Astagneau P; Pulcini C; Robert J; Zahar JR; Sales-Wuillemin E; Tubach F; Lucet JC;
    Antimicrob Resist Infect Control; 2019; 8():173. PubMed ID: 31749961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
    Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
    J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of copper-impregnated composite bed linens and patient gowns on healthcare-associated infection rates in six hospitals.
    Butler JP
    J Hosp Infect; 2018 Nov; 100(3):e130-e134. PubMed ID: 29803808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.